Proton MR Spectroscopy–Detectable Major Neurotransmitters of the Brain: Biology and Possible Clinical Applications
暂无分享,去创建一个
[1] R. Bartha,et al. Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.
[2] Merit Cudkowicz,et al. ALS drug development: Reflections from the past and a way forward , 2008, Neurotherapeutics.
[3] H. Johansen-Berg,et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels , 2010, Epilepsia.
[4] A. Doerfler,et al. Alterations of intracerebral γ‐aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies , 2010, Epilepsia.
[5] P. Renshaw,et al. Update on the use of MR for assessment and diagnosis of psychiatric diseases. , 2010, Radiology.
[6] A. Doerfler,et al. In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? , 2010, European journal of radiology.
[7] Jing Han,et al. Study of the features of proton MR spectroscopy (1H‐MRS) on amyotrophic lateral sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.
[8] R. Bartha,et al. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] H. Biceroglu,et al. The expression of astroglial glutamate transporters in patients with focal cortical dysplasia: an immunohistochemical study , 2010, Acta Neurochirurgica.
[10] Ji-Kyung Choi,et al. Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation , 2009, The European journal of neuroscience.
[11] Kenji Mori,et al. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument , 2009, NeuroImage.
[12] A. Sakamoto,et al. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy , 2009, Epilepsia.
[13] A. Rominger,et al. PET and SPECT in epilepsy: A critical review , 2009, Epilepsy & Behavior.
[14] G. Barker,et al. Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection , 2009, Epilepsy Research.
[15] David Borsook,et al. Excitatory neurotransmitters in brain regions in interictal migraine patients , 2009, Molecular pain.
[16] O. Okonkwo,et al. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia , 2008, Alzheimer's & Dementia.
[17] R. Prost,et al. MR‐spectroscopic findings in juvenile‐onset Huntington's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[18] M. Baslow. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target. , 2008, Drug news & perspectives.
[19] S. Santi,et al. Memantine decreases hippocampal glutamate levels: A magnetic resonance spectroscopy study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[20] Christian Steinhäuser,et al. Astrocytic function and its alteration in the epileptic brain , 2008, Epilepsia.
[21] P. Pollak,et al. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength , 2007, NMR in biomedicine.
[22] Ravi S. Menon,et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia , 2007, British Journal of Psychiatry.
[23] P. Magistretti,et al. Activity‐dependent regulation of energy metabolism by astrocytes: An update , 2007, Glia.
[24] Morris H. Baslow,et al. Using proton magnetic resonance imaging and spectroscopy to understand brain “activation” , 2007, Brain and Language.
[25] F. Nicoletti,et al. The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection , 2007, The Journal of Neuroscience.
[26] K. Obata,et al. Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles—Evidence from GAD65-knockout mice studies , 2007, Brain Research.
[27] J. Moffett,et al. Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy , 2007, Brain Research.
[28] G. Barker,et al. Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy , 2007, Epilepsy Research.
[29] Rolf Gruetter,et al. Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo1H NMR spectroscopy , 2007, Journal of neurochemistry.
[30] R. D. O'Shea,et al. Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement , 2007, British journal of pharmacology.
[31] Morris H. Baslow,et al. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice , 2007, Journal of Molecular Neuroscience.
[32] D. Cleveland,et al. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.
[33] Douglas L. Rothman,et al. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study , 2006, Psychopharmacology.
[34] Rolf Gruetter,et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: Detection of high GABA concentrations , 2006, Magnetic resonance in medicine.
[35] P. Williamson,et al. Brain magnetic resonance spectroscopy in Tourette's disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[36] Clifford R Jack,et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Coyle,et al. NAAG Reduces NMDA Receptor Current in CA1 Hippocampal Pyramidal Neurons of Acute Slices and Dissociated Neurons , 2005, Neuropsychopharmacology.
[38] Piotr Czapiński,et al. Mechanisms of action of antiepileptic drugs. , 2005, Current topics in medicinal chemistry.
[39] J. Neale,et al. Biosynthesis of NAAG by an enzyme‐mediated process in rat central nervous system neurons and glia , 2004, Journal of neurochemistry.
[40] A. Schousboe,et al. Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo , 1985, Neurochemical Research.
[41] John S Duncan,et al. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy , 2003, Neurology.
[42] Pierre J Magistretti,et al. GABA uptake into astrocytes is not associated with significant metabolic cost: Implications for brain imaging of inhibitory transmission , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Rijpkema,et al. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging , 2003, NMR in biomedicine.
[44] K. Abe,et al. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease , 2002, Neuroreport.
[45] S. Laughlin,et al. An Energy Budget for Signaling in the Grey Matter of the Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] R. Mattson,et al. Topiramate Rapidly Raises Brain GABA in Epilepsy Patients , 2001, Epilepsia.
[47] P. Antuono,et al. Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with 1H-MRS at 0.5 T , 2001, Neurology.
[48] Ana Gadea,et al. Glial transporters for glutamate, glycine and GABA I. Glutamate transporters , 2001, Journal of neuroscience research.
[49] E. Cherubini,et al. Generating diversity at GAB Aergic synapses , 2001, Trends in Neurosciences.
[50] B. Weber,et al. Effects of Vigabatrin on Brain GABA+/CR Signals in Patients with Epilepsy Monitored by 1H‐NMR‐Spectroscopy: Responder Characteristics , 2001, Epilepsia.
[51] A. López-Colomé,et al. Glial transporters for glutamate, glycine, and GABA: II. GABA transporters , 2001, Journal of neuroscience research.
[52] E. Cherubini,et al. Generating diversity at GABAergic synapses. , 2001, Trends in neurosciences.
[53] G. Moore,et al. Evidence for Coupling between Glucose Metabolism and Glutamate Cycling Using FDG PET and 1H Magnetic Resonance Spectroscopy in Patients with Epilepsy , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[54] A. Chapman,et al. Glutamate and epilepsy. , 2000, The Journal of nutrition.
[55] R. Shulman,et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] D L Rothman,et al. Acute Effects of Vigabatrin on Brain GABA and Homocarnosine in Patients with Complex Partial Seizures , 1999, Epilepsia.
[57] J S Duncan,et al. Short echo time single‐voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging–negative temporal lobe epilepsy: Different biochemical profile compared with hippocampal sclerosis , 1999, Annals of neurology.
[58] M. Santi,et al. N‐acetylaspartylglutamate activates cyclic AMP‐coupled metabotropic glutamate receptors in cerebellar astrocytes , 1998, Glia.
[59] Prof. Dr. Dr. Valentino Braitenberg,et al. Cortex: Statistics and Geometry of Neuronal Connectivity , 1998, Springer Berlin Heidelberg.
[60] R. Shulman,et al. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Frahm,et al. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS , 1997, NMR in biomedicine.
[62] J. Pin,et al. Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.
[63] R. Mattson,et al. Low brain GABA level is associated with poor seizure control , 1996, Annals of neurology.
[64] P. Magistretti,et al. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[65] C R Houser,et al. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[66] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[67] K. Rimvall,et al. Regulation of γ‐Aminobutyric Acid Synthesis in the Brain , 1993 .
[68] D. L. Martin,et al. Regulation of gamma-aminobutyric acid synthesis in the brain. , 1993, Journal of neurochemistry.
[69] J. Meyerhoff,et al. Activity of a NAAG-hydrolyzing enzyme in brain may affect seizure susceptibility in genetically epilepsy-prone rats. , 1992, Epilepsy research. Supplement.
[70] Jeffrey D. Rothstein,et al. Reductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS , 1991, Brain Research.
[71] J. Coyle,et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.
[72] D. Garfinkel,et al. A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. , 1971, The Biochemical journal.
[73] T. Hayashi,et al. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. , 1952, The Japanese journal of physiology.